Aesthetic Medicine“Ozempic face” and the GLP-1 boom are changing the face of beautyMaroefah Smith 18 hours
Mental healthOzempic, Wegovy and Mounjaro could “fuel the fire” of mental illness, warns psychiatrist7 Sep 2026
PharmaceuticalsAspen to make SA’s hunger for weight-loss drugs its bread and butterNqobile Dludla 3 Sep 2026
Ethics & MedicolegalNovo Nordisk v iDexis: What’s in a name (or, in this case, a compounded medicine)?24 Jul 2026
PharmaceuticalsiDexis appeals High Court’s ruling on Novo Nordisk weight-loss drugsNqobile Dludla 15 Jul 2026
PharmaceuticalsAfter Novo Nordisk legal action, Pretoria pharmacy’s Ozempic copies recalledNqobile Dludla 13 Jul 2026
Natural MedicineWeight-loss drug crackdown will have ripple effect on SA’s longevity market24 Jun 2026
PharmaceuticalsPrice war in weight-loss drugs heats up as Novo Nordisk reduces Wegovy pricesNqobile Dludla 26 Mar 2026
PharmaceuticalsAspen Pharmacare to capitalise on GLP-1 demand in sub-Saharan AfricaNqobile Dludla 4 Mar 2026
PharmaceuticalsRestructuring dents Aspen profits, but Mounjaro sales spark hopeNqobile Dludla 3 Mar 2026
TourismSun’s out, buns out: Is it time for the hospitality sector to brace for the Ozempic effect?Rachel Irvine 17 Dec 2025
PharmaceuticalsWeight loss drug semaglutide shown to be safe and potentially more effective at higher dose – new findingsMartin Whyte 18 Sep 2025
PharmaceuticalsDanish weight-loss drug Wegovy debuts in South Africa, challenging Eli LillyNqobile Dludla and Siyanda Mthethwa 14 Aug 2025
HealthcareThe rise of Ozempic: how surprise discoveries and lizard venom led to a new class of weight-loss drugs11 Apr 2024
PharmaceuticalsEU probes Novo Nordisk drugs after reports of suicidal thoughtsBhanvi Satija 10 Jul 2023
PharmaceuticalsBrand Finance Healthcare 2023 Report reveals resilience amidst post-pandemic slump7 Jul 2023